Allergan India
- All
- News
-
Pharma Company Recalls Eye Implant Product After Defect Found
The Drug Controller General of India has told a pharmaceutical company to recall one of its products, Ozurdex Intravitreal Implant, a steroid eye implant for macular edema, after the company admitted that a silicone particle has been detected in it.
-
Lupin Gets USFDA's Final Nod For Pain Relief Tablets
The tablets are generic version of Allergan Sales LLC's Norco tablets in the same strengths and the product will be launched shortly, Lupin said.
-
Cipla Divests 16.7% Stake In Chase Pharma To Allergan
Delaware-based Chase Pharmaceuticals Corporation, in which the company's UK arm Cipla (EU) Ltd has 16.7 per cent stake, has been acquired by a subsidiary of Allergan plc, Cipla said in a statement.
-
Dr Reddy's Completes Acquisition Of Products From Teva Pharma
Dr Reddy's Laboratories on Wednesday said it has successfully completed the $350-million (around Rs 2,300 crore) acquisition of eight abbreviated new drug applications (ANDAs) in the US from Teva Pharmaceutical Industries and an affiliate of Allergan plc.
-
Dr Reddy's To Buy Eight Products In US For $350 Million
The portfolio consists of products that are being divested by Teva as a precondition to its closing of the acquisition of Allergan's generics business, the Hyderabad-based firm said.
-
Natco Settles Patent Litigation With Celgene on Cancer Drug
Natco Pharma and its US partner Allergan have settled a pending litigation with biopharmaceutical firm Celgene regarding generic Lenalidomide capsules used for treatment of multiple myeloma.
-
Pharma Company Recalls Eye Implant Product After Defect Found
The Drug Controller General of India has told a pharmaceutical company to recall one of its products, Ozurdex Intravitreal Implant, a steroid eye implant for macular edema, after the company admitted that a silicone particle has been detected in it.
-
Lupin Gets USFDA's Final Nod For Pain Relief Tablets
The tablets are generic version of Allergan Sales LLC's Norco tablets in the same strengths and the product will be launched shortly, Lupin said.
-
Cipla Divests 16.7% Stake In Chase Pharma To Allergan
Delaware-based Chase Pharmaceuticals Corporation, in which the company's UK arm Cipla (EU) Ltd has 16.7 per cent stake, has been acquired by a subsidiary of Allergan plc, Cipla said in a statement.
-
Dr Reddy's Completes Acquisition Of Products From Teva Pharma
Dr Reddy's Laboratories on Wednesday said it has successfully completed the $350-million (around Rs 2,300 crore) acquisition of eight abbreviated new drug applications (ANDAs) in the US from Teva Pharmaceutical Industries and an affiliate of Allergan plc.
-
Dr Reddy's To Buy Eight Products In US For $350 Million
The portfolio consists of products that are being divested by Teva as a precondition to its closing of the acquisition of Allergan's generics business, the Hyderabad-based firm said.
-
Natco Settles Patent Litigation With Celgene on Cancer Drug
Natco Pharma and its US partner Allergan have settled a pending litigation with biopharmaceutical firm Celgene regarding generic Lenalidomide capsules used for treatment of multiple myeloma.
